AR goggles guide surgeons to leftover cancer cells in head and neck surgery

NCT ID NCT07686211

First seen Jul 07, 2026 · Last updated Jul 09, 2026 · Updated 2 times

Summary

This study tests a new augmented reality (AR) system designed to help surgeons accurately re-remove tumor tissue during head and neck cancer surgery. After the main tumor is removed, the pathologist checks if any cancer cells remain at the edges (margins). Currently, the surgeon relies on verbal descriptions to find and remove those areas, which can be imprecise because soft tissue deforms after removal. The AR system uses 3D scanning and modeling to map the removed specimen back onto the surgical site, overlaying margin locations directly onto the patient via an AR headset. Surgeons will perform re-resection tasks on cadavers with and without the AR system to compare accuracy and usability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Augmented reality surgical navigation system
What this could lead to
If successful, this AR system could help surgeons remove leftover cancer cells more accurately during head and neck surgery, potentially lowering recurrence rates.
What could go wrong
This is an early-stage study using cadavers, not live patients. The system may not work as well in real surgery, and benefits for patient outcomes are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FELLOW are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Vanderbilt University Medical Center

    RECRUITING

    Nashville, Tennessee, 37232, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.